Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

Edible Oil Products Operating Profit

Improved margins were offset by higher operating expenses, which included investments to grow the business in Asia and Europe.

Fourth quarter results included $29 million of impairment and restructuring charges. These charges primarily relate to the closure of edible oil facilities in Eastern Europe, as well as impairments to goodwill and other intangible assets in India.

Milling Products Operating Profit

Higher raw material and operating costs in wheat milling more than offset improved results in corn milling.

Fourth quarter results included a $13 million impairment charge related to the closure of a wheat milling facility in Brazil. This facility is being replaced by a newer, more efficient facility that will come on-line in 2008.

Financial Costs

Interest expense increased due to higher average borrowings, mostly resulting from the higher prices of agricultural commodity inventories which drove higher average working capital levels.

Foreign exchange gains, incurred primarily on the net U.S. dollar- denominated monetary liability positions of Bunge's Brazilian subsidiaries, were $39 million in the fourth quarter of 2007. These gains largely offset foreign exchange losses on inventories included in gross profit.

Income Taxes

The effective tax rate for the year ended December 31, 2007 was 26%. For the year ended December 31, 2006, Bunge had a tax benefit of $36 million. The increase in the effective tax rate, excluding the one time items which resulted in the tax benefit in 2006, was primarily due to increases in operating earnings in higher tax jurisdictions.

Minority Interest

Minority interest increased when compared to the same quarter in 2006 due to higher earnings at Fosfertil.

Cash Flow

Cash provided by operations in the fourth quarter of 2007 was $254 million compared to cash provided by operations in the fourth quarter
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... (Nasdaq: VIAP ), a biotechnology company focused on ... and metabolic disease, today announced that it has completed ... clinical trial of VIA-2291. ,, The FDG-PET trial ... sites in the US and Canada including Massachusetts General ...
(Date:12/3/2009)... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief ... http://www.beikebiotech.com ), spoke at a conference on ... 22, 2009. Beike is China,s leading,stem cell research ... The conference, organized by the Indian Podiatry ...
(Date:12/2/2009)... announces that a new market research report ... Drug Discovery Technologies - A Global Update ... http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery has ... every pharmaceutical company,s business strategy. There are ...
(Date:12/2/2009)... , - "Bolstering ... Coinciding with the International ... is hosting an international conference in Libreville,(Gabon) on ... The,conference will be attended by government and state ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
... Emisphere,Technologies, Inc. (Nasdaq: EMIS ), announced ... on Thursday, May 8, 2008, at the Westin,Governor ... Jersey. The,meeting will begin at 10:00 a.m. EDT., ... Inc. is a biopharmaceutical company that,focuses on a ...
... WallSt.net,s 3-Minute Press Show is,a daily video ... Shows air Monday through Friday on:, ... in-depth interviews with,public company executives on their company ... to provide viewers with insight into a company,s ...
... researchers at ... with internal solutions, REDWOOD CITY, Calif., April 15 ... life science researchers, and,Pfizer Pharmaceuticals, Inc. (NYSE: PFE ... a strategic,partnership today. This new multi-year partnership promotes enterprise-wide,deployment ...
Other Biology Technology:Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 3Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 3
(Date:12/3/2009)... and animal species can be likened to emptying a museum ... medicines into the trash, or replacing every local cuisine with ... habitats may not just make the world boring. New research ... for catching some nasty disease. , "Habitat destruction and biodiversity ...
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium continues to attract ... from industry and academia with the goal of eradicating ... scientists and other professionals will gather at the Henry ... 9-13, 2009. The symposium is a partnership between the ...
(Date:12/3/2009)... a personality change in warmer water, according to an intriguing ... more aggressive. , Experiments with two species of young damselfish ... time that some reef fish are either consistently timid, or ... marked as water temperatures rise. , A slight lift of ...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 1USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 3Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 1Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 2Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 1Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 2Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 4Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 5Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 6Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 7Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 8
... young, apparently healthy athletes suddenly collapse, it can be due ... have now discovered a genetic modification that leads to cardiac ... can give zebrafish a heart condition. Since the fish have ... could be critical for humans as well. , ...
... Research(R), a revolutionary biometric media research firm specializing ... of Andre Marquis as Senior Vice President of ... for expanding Innerscope,s offering into the growing digital ... innovative digital initiatives for start-ups and Fortune 500 ...
... are being recruited to get outdoors and help track ... and animal behavior. , The USA-National Phenology Network (USA-NPN), ... a new national program built on volunteer observations of ... and resource managers will use these observations to track ...
Other Biology News:Why 'lazy Susan' has a weak heart 2Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing 2Taking the pulse of our planet 2
Human PDGF R beta MAb (Clone # PR7212)...
Rabbit Serum New Zealand or California Origin...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
...
Biology Products: